BRITTANY SMITH: Open Payments
NPI 1225210909 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 70 payments from 14 companies in 2025. Trend: 2023 $1,104 · 2024 $1,409 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $462 |
| Janssen Pharmaceuticals, Inc | 9 | $282 |
| ABBVIE INC. | 7 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| Otsuka America Pharmaceutical, Inc. | 6 | $111 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Neurocrine BioSciences, Inc. | 3 | $77 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $48 |
| Alkermes, Inc. | 2 | $44 |
Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, FANAPT, Auvelity, INGREZZA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
